Детская хирургия. Журнал им. Ю.Ф. Исакова. 2018; 22: 172-178
ХИРУРГИЧЕСКОЕ ЛЕЧЕНИЕ ДЕТЕЙ С НЕЙРОБЛАСТОМОЙ СЛОЖНОЙ АНАТОМИЧЕСКОЙ ЛОКАЛИЗАЦИИ
https://doi.org/10.18821/1560-9510-2018-22-4-172-178Аннотация
Список литературы
1. Berthold F, ed. NB 2004 Trial Protocol for Risk Adapted Treatment of Children with Neuroblastoma. Available at: http://nodgo.org/sites/default/files/protokol_neuroblastoma-1.pdf [Usage date: 30.07.2017].
2. Шаманская Т.В., Качанов Д.Ю., Муфтахова Г.М., Моисеенко Р.А., Усычкина А.Ю., Талыпов С.Р. и др. Опухоли симпатической нервной системы: подходы к дифференциальной диагностике при локализации опухоли в забрюшинном пространстве. Вопросы практической педиатрии. 2014; 9 (3): 66-72.
3. Simon T., Fischer M., Hero B. Individualized therapy in neuroblastoma. Rossiyskiy zhurnal detskoy gematologii i onkologii. 2016; 3(4): 36-47.
4. Рачков В.Е., Сухов М.Н., Козлов Ю.А., Новожилов В.А., Андреев Е.С., Хелая Д.О. Возможности эндовидеохирургии в лечении нейробластом у детей. Детская хирургия. 2014; 6: 18-23.
5. Поляков В.Г., Рябов А.Б., Ким Э.Ф., Лебедев В.И., Казанцев А.П., Керимов П.А. и др. Хирургический метод при опухолях торакоабдоминальной локализации у детей: современное состояние проблемы и опыт клиники. Онкопедиатрия. 2014; 1: 13-9.
6. Rubie H., De Bernardi B., Gerrard M., et al. Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1. J. Clin Oncol. 2011; 29 (4): 449-55.
7. Bagatell R., McHugh K., Naranjo A. et al. Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study. J. Clin. Oncol. 2016; 34 (7): 740-46.
8. McGregor, L.M., Rao B.N., Davidoff A.M., Billups C.A., Hongeng S., Santana V.M. et al. The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children’s Research Hospital Experience. Cancer. 2005; 104 (12): 2837-46.
9. Medary I., Aronson D., Cheung N.K. et al. Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery. Ann. Surg. Oncol. 1996; 3: 521-25.
10. Davidoff A.M., Corey B.L., Hoffer F.A., Santana V.M., Furman W.L., Bowman L.C. et al. Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy. Pediatr. Blood Cancer. 2005; 44 (2): 158-62.
11. La Quaglia M.P., Kushner B.H., Su W., Heller G., Kramer K., Abramson S. et al. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J. Pediatr. Surg. 2004; 39 (3): 412-17.
12. Kiely E.M. The surgical challenge of neuroblastoma. J. Pediatr. Surg. 1994; 29: 128-33.
13. Holmes K., Sarnacki S., Poetschger U., Monclair T., Cecchetto G., Buffa P. et al. Influence of surgical excision on survival of patients with high-risk neuroblastoma. Report from study 1 of SIOP Europe (SIOPEN): Proceedings of Advances in Neuroblastoma Research Congress. 2014, May 13-16; Germany: Cologne, 2014; 107.
14. Brodeur G.M., Pritchard J., Berthold F. et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol. 1993; 11 (8): 1466-77.
15. Cecchetto G., Mosseri V., De Bernardi B., Helardot P., Monclair T., Costa E. et al. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J. Clin. Oncol. 2005; 23 (33): 8483-89.
16. Dindo D., Demartines N., Clavien P.A. Сlassification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery. 2004; 240 (2): 205-13.
17. Zwaveling S. et al. Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95 % tumour resection suffice?. J. Pediatric surgery international. 2012; 28: 953-59.
Russian Journal of Pediatric Surgery. 2018; 22: 172-178
SURGICAL TREATMENT OF CHILDREN WITH NEUROBLASTOMA OF COMPLEX ANATOMICAL LOCALIZATION
https://doi.org/10.18821/1560-9510-2018-22-4-172-178Abstract
References
1. Berthold F, ed. NB 2004 Trial Protocol for Risk Adapted Treatment of Children with Neuroblastoma. Available at: http://nodgo.org/sites/default/files/protokol_neuroblastoma-1.pdf [Usage date: 30.07.2017].
2. Shamanskaya T.V., Kachanov D.Yu., Muftakhova G.M., Moiseenko R.A., Usychkina A.Yu., Talypov S.R. i dr. Opukholi simpaticheskoi nervnoi sistemy: podkhody k differentsial'noi diagnostike pri lokalizatsii opukholi v zabryushinnom prostranstve. Voprosy prakticheskoi pediatrii. 2014; 9 (3): 66-72.
3. Simon T., Fischer M., Hero B. Individualized therapy in neuroblastoma. Rossiyskiy zhurnal detskoy gematologii i onkologii. 2016; 3(4): 36-47.
4. Rachkov V.E., Sukhov M.N., Kozlov Yu.A., Novozhilov V.A., Andreev E.S., Khelaya D.O. Vozmozhnosti endovideokhirurgii v lechenii neiroblastom u detei. Detskaya khirurgiya. 2014; 6: 18-23.
5. Polyakov V.G., Ryabov A.B., Kim E.F., Lebedev V.I., Kazantsev A.P., Kerimov P.A. i dr. Khirurgicheskii metod pri opukholyakh torakoabdominal'noi lokalizatsii u detei: sovremennoe sostoyanie problemy i opyt kliniki. Onkopediatriya. 2014; 1: 13-9.
6. Rubie H., De Bernardi B., Gerrard M., et al. Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1. J. Clin Oncol. 2011; 29 (4): 449-55.
7. Bagatell R., McHugh K., Naranjo A. et al. Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study. J. Clin. Oncol. 2016; 34 (7): 740-46.
8. McGregor, L.M., Rao B.N., Davidoff A.M., Billups C.A., Hongeng S., Santana V.M. et al. The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children’s Research Hospital Experience. Cancer. 2005; 104 (12): 2837-46.
9. Medary I., Aronson D., Cheung N.K. et al. Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery. Ann. Surg. Oncol. 1996; 3: 521-25.
10. Davidoff A.M., Corey B.L., Hoffer F.A., Santana V.M., Furman W.L., Bowman L.C. et al. Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy. Pediatr. Blood Cancer. 2005; 44 (2): 158-62.
11. La Quaglia M.P., Kushner B.H., Su W., Heller G., Kramer K., Abramson S. et al. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J. Pediatr. Surg. 2004; 39 (3): 412-17.
12. Kiely E.M. The surgical challenge of neuroblastoma. J. Pediatr. Surg. 1994; 29: 128-33.
13. Holmes K., Sarnacki S., Poetschger U., Monclair T., Cecchetto G., Buffa P. et al. Influence of surgical excision on survival of patients with high-risk neuroblastoma. Report from study 1 of SIOP Europe (SIOPEN): Proceedings of Advances in Neuroblastoma Research Congress. 2014, May 13-16; Germany: Cologne, 2014; 107.
14. Brodeur G.M., Pritchard J., Berthold F. et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol. 1993; 11 (8): 1466-77.
15. Cecchetto G., Mosseri V., De Bernardi B., Helardot P., Monclair T., Costa E. et al. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J. Clin. Oncol. 2005; 23 (33): 8483-89.
16. Dindo D., Demartines N., Clavien P.A. Slassification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery. 2004; 240 (2): 205-13.
17. Zwaveling S. et al. Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95 % tumour resection suffice?. J. Pediatric surgery international. 2012; 28: 953-59.
